Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Cellularity Classical Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00132028
What this trial is testing

Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Who this might be right for
Adult Favorable Prognosis Hodgkin LymphomaAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin Lymphoma+5 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00742027
What this trial is testing

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Large-scale testing (Phase 3)Study completedNCT00049595
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 552
Testing effectiveness (Phase 2)Study completedNCT00082966
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin Lymphoma+1 more
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Large-scale testing (Phase 3)UnknownNCT00433433
What this trial is testing

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,952
Large-scale testing (Phase 3)Study completedNCT00678327
What this trial is testing

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Who this might be right for
Lymphoma
University College, London 1,202
Testing effectiveness (Phase 2)Study completedNCT01460940
What this trial is testing

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00006760
What this trial is testing

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT00255723
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 98
Large-scale testing (Phase 3)UnknownNCT00041210
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Mount Vernon Cancer Centre at Mount Vernon Hospital 850
Large-scale testing (Phase 3)Study completedNCT00003389
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 854
Testing effectiveness (Phase 2)Study completedNCT01118026
What this trial is testing

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 101
Large-scale testing (Phase 3)Study completedNCT00302003
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Who this might be right for
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin Lymphoma+3 more
Children's Oncology Group 287
Testing effectiveness (Phase 2)Study completedNCT00574496
What this trial is testing

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Large-scale testing (Phase 3)Study completedNCT00433459
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 2,134
Next Page